Codexis and Nestlé Health Science Sign Development Agreement to Advance Therapeutic Candidate towards Clinical Studies and Extend Strategic Collaboration Agreement

Protein engineering

Home » Emerging technologies » Protein engineering

Codexis Announces License Agreement with Roche for Enzyme Used in Next Generation Sequencing

REDWOOD CITY, Calif., Dec. 23, 2019 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces a license agreement to provide Roche with Codexis’ EvoT4TM DNA ligase high...

BP and Arzeda Announce Collaboration Expansion

A Year in Review: Nobel Laureate Frances Arnold at SynBioBeta 2019

2019 has been yet another groundbreaking year for synthetic biology, marked by sustained growth surpassing even the Moore’s Law curve of the silicon microchip boom. From a refined version of CRISPR (prime editing) and...

Codexis Announces the Publication with Merck of an Efficient Enzymatic Cascade Process for Synthesis of Investigational Anti-HIV Agent, Islatravir

phone screen

Molecule Maker Arzeda Wants To Grow Phone Screens That Won’t Scratch

John Lesnick

How Automation and Machine Learning Help Explore the Dark Corners of the Genome

John Nicols

The Medicine Cabinet Of The Future: If You Can Imagine A Drug, This Company Can Make It

Codexis’ Protein Engineering Forum Highlights Progress and Future Direction of the Field

Frances Arnold

Nobelist Frances Arnold Is Nudging Nature To Make Your World Greener, One Small Evolution At A Time

Engineering the future of biotherapeutics

DNA

Synthetic biology’s Lego kit: Brought to you by Arzeda, TeselaGen, Twist Bioscience, and Labcyte

Cyrus Biotechnology Offers CryoEM Services Based on First-in-class, Peer-reviewed Rosetta Software Methods

Cyrus Biotechnology Significantly Expands Customer Engagement through Biotherapeutic Partnerships and Fee-for-Service Scientific Consulting

Codexis Reports Second Quarter 2019 Financial Results

In research news this week: Smart cell therapies, new base editing technology, synthetic cells, and more